SLQT (42) HUIZ (68) CCG (47) RDZN (22) ⌘ Pro Terminal →

Health In Tech Inc. (Class A) (HIT) — RQD Stock Rating Cockpit

$0.61 -5.89% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $0.60

Health In Tech Inc. (Class A) (HIT) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $39.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $0.60 (-1.25%)🧬 Cannibal Buyback (-2.08% YoY Shares)⚙️ Cash Engine: 15/20 (B) • 9.4% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C+ · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE+1.6% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for HIT)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (63/100 Composite)

🔍 WHY HIT SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Cash Engine Quality+15/20 pts (24% of score)

SEC XBRL FY 2025 (10-K): 9.4% FCF Margin ($3.1M FCF) & 52% Gross Margin

▲ #2 Bullish Driver: Insider Conviction & Share Dilution+15/20 pts (24% of score)

SEC Form 4 / 13F Thermometer: 75% Net Buy • Cannibal Buyback (-2.08% YoY Shares)

▼ #1 Drag / Risk Factor: Macro Regime Fit10/20 pts (-10 pt drag)

Macro rate sensitivity & RSI-14 (37.3) create a -10 pt regime headwind

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$0.74-12.2% Next Q

Q2 (-2Q)

Grade B-$0.65-13.8% Next Q

Q3 (-1Q)

Grade B-$0.56+8.9% Next Q

Current

Grade C$0.61+0.9% Hist 90D α

Trajectory: B (71) → C (63)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the HIT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, HIT faces multiple-compression risk if 31.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Sensitive to high interest rates and tighter Federal Reserve market liquidity.

⚠️ Forensic Kill-Switch #2

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($0.81) or 200D SMA ($1.15) invalidates the momentum regime and cuts Target Base ($0.62) toward Bear Floor ($0.48).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $HIT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “HIT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 63%NO 37%Trade / Inspect Odds →

RSI-14 MOMENTUMNEUTRAL RANGE

37.330 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREHIGH QUALITY (7–9)

7 / 99-Pt Accounting

52-WEEK LASER RANGE4% OF RANGE

L: $1$0.61H: $3

1. Money & Cash Health● HEALTHY

Are profits real cash in the bank?

Real cash coming in backs up reported profits (steady margins and healthy balance-sheet cushion).

Factor Grade: BRQD 15 / 20

2. Big Money & Insiders● NEUTRAL

Are whales & executives buying or selling?

Big funds and company insiders are mostly holding steady without aggressive buying or panic selling.

Factor Grade: CRQD 26 / 40

3. Hidden Risks & Market Weather● WATCH

SEC fine-print scan & interest-rate fit

No major SEC filing blowups, though current interest rates and Fed liquidity call for normal position sizing.

Factor Grade: D+RQD 22 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

JEV AI Jury Split (Battleground) on HIT

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BULLISH (75)

7.5% ROIC with 42.0% gross margin and 7.85% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

NEUTRAL (60)

Altman-Z 4.20 and Piotroski 7/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

NEUTRAL (60)

26/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like HIT

✓Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.
✓Company leadership has skin in the game with net positive insider conviction.

Bear Case: What Could Go Wrong

!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (HIT Tape Review)

✓Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
✓Forensic Red-Light accounting & dilution traps to review on your watchlist
✓Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

HIT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -57.93%▼ DESCENDING CHANNEL

2026-10-30O $0.63H $0.65L $0.58C $0.61VOL 25.1K

RES: $0.79SUP: $0.43SMA50: $0.81SMA200: $1.15

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

HIT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 HIT Butterfly Map → + Track HIT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

24.1%/yr Implied 5Y Growth

vs. +71.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on HIT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for HIT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for HIT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (HIT)

Financials Rank #412 of 1096 ⚔️ SLQT vs HIT Full Matrix →

1. Head-to-Head Financials Peer Comparison (HIT vs. SLQT, HUIZ, CCG, RDZN)

Industry: Specialty Insurers (33 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Health In Tech Inc. (Class A) (HIT) ranks #412 by composite RQD confidence (63/100, grade C) and #1024 by equity capitalization ($39.9M). Within this direct 5-issuer industry benchmark cohort, HIT leads on earnings valuation at 31.2x trailing P/E, while HIT leads on capital efficiency and profitability with 7.5% ROIC and — gross margin. HUIZ currently holds the highest overall quantitative score in the immediate peer group at 68/100 (C+) compared with HIT at 63/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
HIT ACTIVE Health In Tech Inc. (Class A)	C	63/100	31.2x	—	7.5%	-5.89%	$39.9M	Benchmark Subject
SLQT SelectQuote Inc.	D-	42/100	—	—	7.4%	-0.47%	$64.9M	/slqt-vs-hit →
HUIZ Huize Holding Limited	C+	68/100	39.0x	—	3.1%	+6.19%	$22.5M	/huiz-vs-hit →
CCG Cheche Group Inc. (Class A)	D	47/100	—	—	—	-4.33%	$18.8M	/ccg-vs-hit →
RDZN Roadzen Inc.	E	22/100	—	—	-35.0%	-2.61%	$95.4M	/rdzn-vs-hit →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0002019505

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Health In Tech Inc. (Class A) (HIT) reported GAAP revenue of $33.3M (+71.0% vs. FY2024 revenue of $19.5M , and +74.0% cumulative change since FY2023) , GAAP net income of $1.3M, operating cash flow of $3.1M, and free cash flow of $3.1M (+44.0% YoY). On the balance sheet, HIT closed FY2025 with $23.1M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 7/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$33.3M	$1.3M	$3.1M	$3.1M	$23.1M	—
FY2024 (FY)	2024-12-31	$19.5M	$670.5K	$2.2M	$2.2M	$15.8M	—
FY2023 (FY)	2023-12-31	$19.2M	$0	$1.5M	$1.5M	—	—

3. HIT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is HIT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Health In Tech Inc. (Class A) (NASDAQ: HIT) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $0.61 (-5.89% 1D, market cap $39.9M). Pillar breakdown: Fundamental Cash Engine 15/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 12/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 15/20. Across 1096 tracked Financials issuers, HIT ranks #412 in composite RQD confidence.

How does HIT compare to SLQT and HUIZ in the Financials sector?

Within the Financials sector (Specialty Insurers), HIT carries a Roarable C (63/100 RQD), trailing P/E of 31.2x, gross margin of —, and ROIC of 7.5%. By comparison, SLQT (SelectQuote Inc.) holds a D- grade (42/100 RQD, P/E N/A, ROIC 7.4%, cap $64.9M) and HUIZ (Huize Holding Limited) posts a C+ grade (68/100 RQD, P/E 39.0x, ROIC 3.1%, cap $22.5M). Among the 5-stock peer group, HIT leads on earnings multiple (31.2x) while HIT leads on capital efficiency (7.5% ROIC).

What are the biggest fundamental strengths and SEC risk factors for HIT?

Per HIT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0002019505), Health In Tech Inc. (Class A) generated $33.3M in revenue (+71.0% YoY), $1.3M in net income, and $3.1M in free cash flow against $23.1M in total assets and $0 in total debt. Key quantitative strengths: Strong cash generator (steady margins)—profits are backed by real money, not accounting tricks.. Primary risk factors monitored: Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is HIT trading relative to its 50-day, 200-day, and 52-week technical levels?

HIT last traded at $0.61 (-5.89% on volume of 94,251 shares), positioning the stock -24.69% below its 50-day simple moving average ($0.81) and -46.96% below its 200-day simple moving average ($1.15). Across its 52-week range of $0.50 to $3.11, HIT sits at the 4.2% percentile with a 14-day RSI of 37.3 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.00 to $0.69).

HIT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell HIT stock right now?

Health In Tech Inc. (Class A) (HIT) currently earns a Roarable Rating of C (Hold — HOLD) with 63/100 RQD Confidence. Solid steady margins (8% return on capital), mixed timing at 31x P/E—hold if owned, no rush to chase.

What is HIT's 12-month price target and RQD AI Jury consensus?

HIT's 12-month base price target is $0.62 (range $0.48 to $3.27), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: HIT RQD Cockpit HIT 12M Forecast HIT Earnings & Move HIT Dividends & DRIP HIT Insiders & 13F HIT Whale Options HIT Profit Sankey HIT News & Why